Reduction in incidence of methicillin-resistant Staphylococcus aureus (MRSA) after radical surgery for head and neck cancer

Special Care in Dentistry

Volumn 26, Issue 5, 2006, Pages 209-213

  Morimoto, Yoshinari ^a,b   Sugiura, Tsutomu ^b   Tatebayashi, Shigeru ^b   Kirita, Tadaaki ^b  

^a OSAKA UNIVERSITY   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Antibiotics; Blood loss; Head and neck cancer; Methicillin resistant staphylococcus aureus (MRSA); Operation time

Indexed keywords

ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE; IMIPENEM;

ARTICLE; BLEEDING; CHI SQUARE DISTRIBUTION; CROSS INFECTION; DRUG EFFECT; FEMALE; HEAD AND NECK TUMOR; HUMAN; INCIDENCE; INFECTION CONTROL; JAPAN; MALE; MICROBIOLOGY; NONPARAMETRIC TEST; ORAL SURGERY; PATHOPHYSIOLOGY; PENICILLIN RESISTANCE; POSTOPERATIVE COMPLICATION; RISK FACTOR; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SURGICAL INFECTION; TIME;

ANTI-BACTERIAL AGENTS; BLOOD LOSS, SURGICAL; CEPHALOSPORINS; CHI-SQUARE DISTRIBUTION; CROSS INFECTION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMIPENEM; INCIDENCE; INFECTION CONTROL; JAPAN; MALE; METHICILLIN RESISTANCE; ORAL SURGICAL PROCEDURES; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STATISTICS, NONPARAMETRIC; SURGICAL WOUND INFECTION; TIME FACTORS;

EID: 33750419005     PISSN: 02751879     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1754-4505.2006.tb01440.x     Document Type: Article

References (23)

1. Girou E, Pujade G, Legrand P, Cizeau F, Brun-Buisson CB. Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with a high level of endemic MRSA. Clin Infect Dis 1998;27:543-50.
2. Kac G, Buu-Hoï A, Hérisson E, Biancardini P, Debure C. Methicillin-resistant Staphylococcus aureus Nosocomial acquisition and carrier state in a wound care center. Arch Dermatol 2000;136:735-9.
3. Rampling A, Wiseman S, Davis L et al. Evidence that hospital hygiene is important in the control of methicillin-resistant Staphylococcus aureus. J Hosp Infect 2001;49:109-16.
4. Mishal J, Sherer Y, Levin Y, Katz D, Embon E. Two-stage evaluation and intervention program for control of methicillin-resistant Staphylococcus aureus in the hospital setting. Scand J Infect Dis 2001;33:498-501.
5. Barakate MS, Harris JP, West RH et al. A prospective survey of current methicillin-resistant Staphylococcus aureus control measures. Aust NZJ Surg 1999;69:712-6.
6. Barakate MS, Yang YX, Foo SH et al. An epidemiological survey of methicillin-resistant Staphylococcus aureus in a tertiary referral hospital. J Hosp Infect 2000;44:19-26.
7. Kendall JB, Hart CA, Pennefather SH, Russell GN. Infection control measures for adult cardiac surgery in the UK-a survey of current practice. J Hosp Infect 2003;54:174-8.
8. Landman D, Chockalingam M, Quale JM. Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary. Clin Infect Dis 1999;28:1062-6.
9. Smith DW: Decreased antimicrobial resistance after changes in antibiotic use. Pharmacotherapy 1999;19:1295-325.
10. Graffunder E, Venezia RA. Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimic Chemoth 2002;49:999-1005.
11. Fukatsu K, Saito H, Matsuda T, Ikeda S, Furukawa S, Muto T. Influences of type and duration of antimicrobial prophylaxis on an outbreak of methicillin-resistant Staphylococcus aureus and on the incidence of wound infection. Arch Surg 1997;132:1320-5.
12. Kusachi S, Sumiyama Y, Nagao J et al. New methods of control against postoperative methicillin-resistant Staphylococcus aureus infection. Surg Today 1999;29:724-9.
13. Yoshida I, Kimura I, Higashiyama I, Sugimori G, Yamano Y. Surveillance of susceptibility of clinical isolates of various bacterial species to antibacterial agents. J Antimicrobi Chemother 2003;51:179-208. (in Japanese)
14. Hiramatsu K. Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Infect Dis 2001;1:147-55.
15. Katayama Y, Ito T, Hiramatsu K. A new class of genetic element Staphylococcus Cassette Chromosome mec, encodes methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 2000;44:1549-55.
16. Ishida H, Yokoyama M, Nakada H, Inokuma S, Hashimoto D. Impact of oral antimicrobial prophylaxis on surgical site infection and methicillin-resistant Staphylococcus aureus infection after elective colorectal surgery. Results of a postoperative randomized trial. Surg Today 2001;31:979-83.
17. Manian FA, Meyer PL, Setzer J, Senkel D. Surgical site infections associated with methicillin-resistant Staphylococcus aureus: do postoperative factors play a role?: Clin Infect Dis 2003;36:863-8.
18. Nichols RL. Postoperative infections in the age of drug-resistant gram-positive bacteria. Am J Med 1998;104(5A):11S-16S.
19. Gnanalinham KK, Elsaghier A, Kibbler C, Shieff A. The impact of methicillin-resistant Staphylococcus aureus in a neurosurgical unit- a growing problem. J Neurosurg 2003;98:8-13.
20. Yano M, Doki Y, Inoue M, Tsujinaka T, Shiozaki H, Monden M. Preoperative intranasal mupirocin ointment significantly reduces postoperative infection with Staphylococcus aureus in patients undergoing upper gastrointestinal surgery. Surg Today 2000;30:16-21.
21. Wilcox MH, Hall J, Pike H et al Use of preoperative mupirocin to prevent methicillin-resistant Staphylococcus aureus (MRSA) orthopaedic surgical site infections. J Hosp Infect 2003;54:196-201.
22. Suzuki Y, Kamigaki T, Fujino Y, Tominaga M, Ku Y, Kuroda Y. Randomized clinical trial of preoperative intranasal mupirocin to reduce surgical-site infection after digestive surgery. Br J Surg 2003;90:1072-5.
23. Warshawsky B, Hussain Z, Gregson DB et al. Hospital- and community-based surveillance of methicillin-resistant Staphylococcus aureus: previous hospitalization is the major risk factor. Infect Control Hosp Epidemiol 2000;21:724-7.